Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Cash from Investing Activities (2016 - 2025)

Fate Therapeutics' Cash from Investing Activities history spans 14 years, with the latest figure at $27.6 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 21.1% year-over-year to $27.6 million; the TTM value through Dec 2025 reached $111.2 million, up 809.85%, while the annual FY2025 figure was $111.2 million, 809.85% up from the prior year.
  • Cash from Investing Activities reached $27.6 million in Q4 2025 per FATE's latest filing, up from $21.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $80.4 million in Q3 2022 to a low of -$471.9 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is $3.9 million, with a median of $25.1 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: crashed 2084.89% in 2021, then surged 3036.37% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at $71.3 million in 2021, then dropped by 25.49% to $53.1 million in 2022, then decreased by 14.61% to $45.4 million in 2023, then plummeted by 49.69% to $22.8 million in 2024, then grew by 21.1% to $27.6 million in 2025.
  • Per Business Quant, the three most recent readings for FATE's Cash from Investing Activities are $27.6 million (Q4 2025), $21.3 million (Q3 2025), and $19.6 million (Q2 2025).